{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:47:52Z","timestamp":1792806472779,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15 \/ 01285"],"award-info":[{"award-number":["PI15 \/ 01285"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundacion Marques de Valdecilla"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s11033-020-05781-0","type":"journal-article","created":{"date-parts":[[2020,9,20]],"date-time":"2020-09-20T04:02:16Z","timestamp":1600574536000},"page":"7125-7138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Serum CGRP, VIP, and PACAP usefulness in migraine: a case\u2013control study in chronic migraine patients in real clinical practice"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-636X","authenticated-orcid":false,"given":"Sara","family":"P\u00e9rez-Pereda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Toriello-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Ocejo-Vinyals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guiral-Foz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Castillo-Obeso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Montes-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Mart\u00ednez-Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Gonz\u00e1lez-Quintanilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7457-9129","authenticated-orcid":false,"given":"Agustin","family":"Oterino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,20]]},"reference":[{"key":"5781_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10194-005-0153-6","volume":"6","author":"P Geppetti","year":"2005","unstructured":"Geppetti P, Capone JG, Trevisani M, Nicoletti P, Zagli G, Tola MR (2005) CGRP and migraine: neurogenic inflammation revisited. J Headache Pain 6:61\u201370","journal-title":"J Headache Pain"},{"key":"5781_CR2","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","volume":"6","author":"TW Ho","year":"2010","unstructured":"Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6:573\u2013582","journal-title":"Nat Rev Neurol"},{"key":"5781_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1177\/0333102410382794","volume":"31","author":"J Mat\u00edas-Guiu","year":"2011","unstructured":"Mat\u00edas-Guiu J, Porta-Etessam J, Mateos V, D\u00edaz-Insa S, Lopez-Gil A, Fern\u00e1ndez C et al (2011) One-year prevalence of migraine in Spain: a nationwide population-based survey. Cephalalgia marzo de 31:463\u2013470","journal-title":"Cephalalgia marzo de"},{"key":"5781_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1468-2982.2009.01941.x","volume":"30","author":"JL Natoli","year":"2010","unstructured":"Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L et al (2010) Global prevalence of chronic migraine: a systematic review. Cephalalgia 30:599\u2013609","journal-title":"Cephalalgia"},{"key":"5781_CR5","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/head.12174","volume":"53","author":"P Durham","year":"2013","unstructured":"Durham P, Papapetropoulos S (2013) Biomarkers associated with migraine and their potential role in migraine management. Headache 53:1262\u20131277","journal-title":"Headache"},{"key":"5781_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1136\/jnnp.2009.192492","volume":"81","author":"DC Buse","year":"2010","unstructured":"Buse DC, Manack A, Serrano D, Turkel C, Lipton RB (2010) Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry 81:428\u2013432","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5781_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10194-018-0883-x","volume":"19","author":"MJ Lee","year":"2018","unstructured":"Lee MJ, Lee S-Y, Cho S, Kang E-S, Chung C-S (2018) Feasibility of serum CGRP measurement as a biomarker of chronic migraine: a critical reappraisal. J Headache Pain 19:53","journal-title":"J Headache Pain"},{"key":"5781_CR8","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1468-29821995.1505384.x","volume":"15","author":"V Gallai","year":"1995","unstructured":"Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G et al (1995) Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 15:384\u2013390","journal-title":"Cephalalgia"},{"key":"5781_CR9","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1212\/WNL.0b013e31826170ce","volume":"79","author":"X Rodr\u00edguez-Osorio","year":"2012","unstructured":"Rodr\u00edguez-Osorio X, Sobrino T, Brea D, Mart\u00ednez F, Castillo J, Leira R (2012) Endothelial progenitor cells: a new key for endothelial dysfunction in migraine. Neurology 79:474\u2013479","journal-title":"Neurology"},{"key":"5781_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.pain.2006.09.017","volume":"128","author":"E Fusayasu","year":"2007","unstructured":"Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K (2007) Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128:209\u2013214","journal-title":"Pain"},{"key":"5781_CR11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"5781_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0304-3959(00)00232-3","volume":"86","author":"M Ashina","year":"2000","unstructured":"Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J (2000) Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 86:133\u2013138","journal-title":"Pain"},{"key":"5781_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1468-2982.2005.01016.x","volume":"26","author":"P Sarchielli","year":"2006","unstructured":"Sarchielli P, Pini LA, Zanchin G, Alberti A, Maggioni F, Rossi C et al (2006) Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders. Cephalalgia 26:257\u2013265","journal-title":"Cephalalgia"},{"key":"5781_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ana.20605","volume":"58","author":"JF Tvedskov","year":"2005","unstructured":"Tvedskov JF, Lipka K, Ashina M, Iversen HK, Schifter S, Olesen J (2005) No increase of calcitonin gene-related peptide in jugular blood during migraine. Ann Neurol 58:561\u2013568","journal-title":"Ann Neurol"},{"key":"5781_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0333102409351807","volume":"30","author":"L Edvinsson","year":"2010","unstructured":"Edvinsson L, Ekman R, Goadsby PJ (2010) Measurement of vasoactive neuropeptides in biological materials: problems and pitfalls from 30 years of experience and novel future approaches. Cephalalgia 30:761\u2013766","journal-title":"Cephalalgia"},{"key":"5781_CR16","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1097\/j.pain.0000000000000119","volume":"156","author":"E Cernuda-Moroll\u00f3n","year":"2015","unstructured":"Cernuda-Moroll\u00f3n E, Ram\u00f3n C, Mart\u00ednez-Camblor P, Serrano-Pertierra E, Larrosa D, Pascual J (2015) OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine. Pain 156:820\u2013824","journal-title":"Pain"},{"key":"5781_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/head.13211","volume":"58","author":"C Dom\u00ednguez","year":"2018","unstructured":"Dom\u00ednguez C, Vieites-Prado A, P\u00e9rez-Mato M, Sobrino T, Rodr\u00edguez-Osorio X, L\u00f3pez A et al (2018) CGRP and PTX3 as predictors of efficacy of onabotulinumtoxin type a in chronic migraine: an observational study. Headache 58:78\u201387","journal-title":"Headache"},{"key":"5781_CR18","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","volume":"81","author":"E Cernuda-Moroll\u00f3n","year":"2013","unstructured":"Cernuda-Moroll\u00f3n E, Larrosa D, Ram\u00f3n C, Vega J, Mart\u00ednez-Camblor P, Pascual J (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81:1191\u20131196","journal-title":"Neurology"},{"key":"5781_CR19","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/head.12372","volume":"54","author":"E Cernuda-Moroll\u00f3n","year":"2014","unstructured":"Cernuda-Moroll\u00f3n E, Mart\u00ednez-Camblor P, Ram\u00f3n C, Larrosa D, Serrano-Pertierra E, Pascual J (2014) CGRP and VIP levels as predictors of efficacy of Onabotulinumtoxin type A in chronic migraine. Headache 54:987\u2013995","journal-title":"Headache"},{"key":"5781_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/0333102414535111","volume":"35","author":"E Cernuda-Moroll\u00f3n","year":"2015","unstructured":"Cernuda-Moroll\u00f3n E, Mart\u00ednez-Camblor P, Alvarez R, Larrosa D, Ram\u00f3n C, Pascual J (2015) Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine. Cephalalgia 35:310\u2013316","journal-title":"Cephalalgia"},{"key":"5781_CR21","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/head.12949","volume":"56","author":"E Cernuda-Moroll\u00f3n","year":"2016","unstructured":"Cernuda-Moroll\u00f3n E, Riesco N, Mart\u00ednez-Camblor P, Serrano-Pertierra E, Garc\u00eda-Cabo C, Pascual J (2016) No change in interictal PACAP levels in peripheral blood in women with chronic migraine. Headache 56:1448\u20131454","journal-title":"Headache"},{"key":"5781_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s10194-018-0893-8","volume":"19","author":"E Rubio-Beltr\u00e1n","year":"2018","unstructured":"Rubio-Beltr\u00e1n E, Correnti E, Deen M, Kamm K, Kelderman T, Papetti L et al (2018) PACAP38 and PAC1 receptor blockade: a new target for headache? J Headache Pain 19:64","journal-title":"J Headache Pain"},{"key":"5781_CR23","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/0333102413483931","volume":"33","author":"B Tuka","year":"2013","unstructured":"Tuka B, Helyes Z, Markovics A, Bagoly T, Szolcs\u00e1nyi J, Szab\u00f3 N et al (2013) Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients. Cephalalgia 33:1085\u20131095","journal-title":"Cephalalgia"},{"key":"5781_CR24","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/acn3.113","volume":"1","author":"AS Zagami","year":"2014","unstructured":"Zagami AS, Edvinsson L, Goadsby PJ (2014) Pituitary adenylate cyclase activating polypeptide and migraine. Ann Clin Transl Neurol 1:1036\u20131040","journal-title":"Ann Clin Transl Neurol"},{"key":"5781_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cca.2015.08.017","volume":"450","author":"X Han","year":"2015","unstructured":"Han X, Dong Z, Hou L, Wan D, Chen M, Tang W et al (2015) Interictal plasma pituitary adenylate cyclase-activating polypeptide levels are decreased in migraineurs but remain unchanged in patients with tension-type headache. Clin Chim Acta 450:151\u2013154","journal-title":"Clin Chim Acta"},{"key":"5781_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16\u201325","journal-title":"Brain"},{"key":"5781_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","volume":"22","author":"LH Lassen","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54\u201361","journal-title":"Cephalalgia"},{"key":"5781_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","volume":"376","author":"L Edvinsson","year":"2010","unstructured":"Edvinsson L, Linde M (2010) New drugs in migraine treatment and prophylaxis: telcagepant and topiramate. Lancet 376:645\u2013655","journal-title":"Lancet"},{"key":"5781_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/0333102413500727","volume":"34","author":"R Marcus","year":"2014","unstructured":"Marcus R, Goadsby PJ, Dodick D, Stock D, Manos G, Fischer TZ (2014) BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia 34:114\u2013125","journal-title":"Cephalalgia"},{"key":"5781_CR30","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1177\/0333102416653233","volume":"36","author":"T Voss","year":"2016","unstructured":"Voss T, Lipton RB, Dodick DW, Dupre N, Ge JY, Bachman R et al (2016) A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia 36:887\u2013898","journal-title":"Cephalalgia"},{"key":"5781_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1468-2982.2007.01497.x","volume":"28","author":"A Rahmann","year":"2008","unstructured":"Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226\u2013236","journal-title":"Cephalalgia"},{"key":"5781_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10194-018-0850-6","volume":"19","author":"JA Waschek","year":"2018","unstructured":"Waschek JA, Baca SM, Akerman S (2018) PACAP and migraine headache: immunomodulation of neural circuits in autonomic ganglia and brain parenchyma. J Headache Pain 19:23","journal-title":"J Headache Pain"},{"key":"5781_CR33","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1177\/0333102415593087","volume":"36","author":"N Riesco","year":"2016","unstructured":"Riesco N, P\u00e9rez-Alvarez AI, Verano L, Garc\u00eda-Cabo C, Mart\u00ednez-Ramos J, S\u00e1nchez-Lozano P et al (2016) Prevalence of cranial autonomic parasympathetic symptoms in chronic migraine: Usefulness of a new scale. Cephalalgia 36:346\u2013350","journal-title":"Cephalalgia"},{"key":"5781_CR34","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11916-017-0618-8","volume":"21","author":"N Riesco","year":"2017","unstructured":"Riesco N, Cernuda-Moroll\u00f3n E, Pascual J (2017) Neuropeptides as a Marker for Chronic Headache. Curr Pain Headache Rep 21:18","journal-title":"Curr Pain Headache Rep"},{"key":"5781_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders. Cephalalgia 33:629\u2013808","journal-title":"Cephalalgia"},{"key":"5781_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/WCO.0000000000000440","volume":"30","author":"C Ram\u00f3n","year":"2017","unstructured":"Ram\u00f3n C, Cernuda-Moroll\u00f3n E, Pascual J (2017) Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine. Curr Opin Neurol 30:281\u2013286","journal-title":"Curr Opin Neurol"},{"key":"5781_CR37","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0333102416653232","volume":"37","author":"N Riesco","year":"2017","unstructured":"Riesco N, Cernuda-Moroll\u00f3n E, Mart\u00ednez-Camblor P, P\u00e9rez-Alvarez AI, Verano L, Garc\u00eda-Cabo C et al (2017) Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: a study in chronic migraine patients. Cephalalgia 37:823\u2013827","journal-title":"Cephalalgia"},{"key":"5781_CR38","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/j.1526-4610.2006.00444.x","volume":"46","author":"L Kelman","year":"2006","unstructured":"Kelman L (2006) Migraine changes with age: IMPACT on migraine classification. Headache 46:1161\u20131171","journal-title":"Headache"},{"key":"5781_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/00365519009091595","volume":"50","author":"S Valdemarsson","year":"1990","unstructured":"Valdemarsson S, Edvinsson L, Hedner P, Ekman R (1990) Hormonal influence on calcitonin gene-related peptide in man: effects of sex difference and contraceptive pills. Scand J Clin Lab Invest 50:385\u2013388","journal-title":"Scand J Clin Lab Invest"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05781-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05781-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T20:02:38Z","timestamp":1632081758000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05781-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["5781"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05781-0","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"17 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Ethics Committee of Cantabria of Cantabria, Spain, approved this study (2015.155) and each patient provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}